Evidence map›Paper›PMID 35382523›Full record

ArticleJournal of scleroderma and related disorders2020

Characteristics of patients with systemic sclerosis suffering from a lower limb amputation: Results of a French collaborative study.

Julien Bertolino, Elisabeth Jouve, Sophie Skopinski, Christian Agard, Aurélie Achille, Benjamin Thoreau, Elisabeth Diot, Sebastien Sanges, Sabine Berthier, Benjamin Chaigne and 9 more

Open access · greenAbstract read
In one paragraph

Article in Journal of scleroderma and related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Julien BertolinoInternal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.ORCID https://orcid.org/0000-0003-4537-4201
Elisabeth JouveMedical Evaluation Service, AP-HM, CIC-CPCET, Marseille, France.ORCID https://orcid.org/0000-0002-4873-6522
Sophie SkopinskiVascular Medicine Department, Hôpital St André, Bordeaux, France.
Christian AgardInternal Medicine Department, CHU Nantes, Nantes, France.
Aurélie AchilleInternal Medicine Department, CHU Nantes, Nantes, France.
Benjamin ThoreauInternal Medicine Department, CHU Tours, Tours, France.ORCID https://orcid.org/0000-0002-9046-4524
Elisabeth DiotInternal Medicine Department, CHU Tours, Tours, France.
Sebastien SangesUniversity of Lille, U995-LIRIC-Lille Inflammation Research International Center, INSERM, U995, CHU Lille, Internal Medicine and Clinical Immunology Department, Lille, France, Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille, France.
Sabine BerthierInternal Medicine and Clinical Immunology Department, CHU Dijon, Dijon, France.
Benjamin ChaigneInternal Medicine Department, Reference Center for Rare Systemic Autoimmune Diseases of Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Alexis RégentInternal Medicine Department, Reference Center for Rare Systemic Autoimmune Diseases of Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Thierry MartinClinical Immunology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Gregory PugnetInternal Medicine Department, Hôpital Purpan, CHU Toulouse, Toulouse, France.
Audrey BenyamineInternal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.
Pascal RossiInternal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.
David LaunayUniversity of Lille, U995-LIRIC-Lille Inflammation Research International Center, INSERM, U995, CHU Lille, Internal Medicine and Clinical Immunology Department, Lille, France, Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille, France.
Luc MouthonInternal Medicine Department, Reference Center for Rare Systemic Autoimmune Diseases of Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Brigitte GranelInternal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.
French Research Group on Systemic Sclerosis (GFRS)
Hôpital Nord · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Tours · FRHôpital Cochin · FRInserm · FRAssistance Publique Hôpitaux de Marseille · FRCHU Dijon Bourgogne · FRHôpital Purpan · FRHôpital Saint-André · FRHôpitaux Universitaires de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Systemic sclerosis mainly affects the microvascular network. However, macrovascular manifestations have been reported. We aimed to investigate the characteristics of systemic sclerosis patients with an amputation of a lower limb segment. Methods: We designed a retrospective, case-control, multicentric study on systemic sclerosis patients with amputation of a lower limb segment secondary to critical ischemia via the French Research Group on Systemic Sclerosis. For each case, a control (systemic sclerosis patient without lower limb symptom) was matched with sex, age (±5 years), and cutaneous subset of systemic sclerosis. Results: In total, 26 systemic sclerosis patients (mean age of 67.2 ± 10.9 years, 20 females, 21 limited cutaneous forms) with a lower limb amputation and 26 matched controls (mean age of 67.3 ± 11.2 years, 20 females, 22 limited cutaneous forms) were included. At the time of amputation, the mean disease duration was 12.8 (±8.6) years. In comparison to controls, systemic sclerosis patients with amputation had more digital ulcers (p = 0.048), history of digital ulcers (p = 0.026), and a higher prevalence of pulmonary arterial hypertension (p = 0.024). Systemic sclerosis patients with amputation were more often smokers (p = 0.008) and under corticosteroids (p = 0.015). In the multivariate model, pulmonary arterial hypertension, smoking status, and corticosteroids were independent markers associated with lower limb amputation in systemic sclerosis. In the follow-up, 10 patients (38.5%) had recurrent ischemia requiring a new limb amputation, and five patients (19.2%) had an amputation of the contralateral limb. Conclusion: This study identifies some markers associated with lower limb amputation in systemic sclerosis such as digital ulcers and pulmonary arterial hypertension and points out the high risk associated with tobacco consumption and corticosteroid use.

Indexed as

amputationlower limbmacrovascular diseasepulmonary arterial hypertensionSystemic sclerosis

Identifiers

PMID35382523
PMCPMC8922619
OpenAlexW3018844570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.